SARS-CoV-2-inactivated vaccine hesitancy and the safety in inflammatory bowel disease patients: a single-center study.

Yubin CaoJiaming FengShihao DuanYi YangYan Zhang

Published in: Therapeutic advances in gastroenterology (2022)

SARS-CoV-2-inactivated vaccination rates in IBD patients are still low and a significant proportion of patients are hesitant about the vaccine because of safety concerns. SARS-CoV-2-inactivated vaccination in patients with IBD appears to be safe.

Keyphrases

sars cov
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
patient reported outcomes
respiratory syndrome coronavirus
coronavirus disease